BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 4758424)

  • 21. Absolute bioavailability of digoxin tablets.
    Beveridge T; NĂ¼esch E; Ohnhaus EE
    Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.
    Shaw TR; Raymond K; Howard MR; Hamer J
    Br Med J; 1973 Dec; 4(5895):763-6. PubMed ID: 4758573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
    Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissimilarities of digoxin.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(24):1376-7. PubMed ID: 5121194
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioavailability of drugs: the digoxin dilemma.
    Greenblatt DJ; Smith TW; Koch-Weser J
    Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation in the biological availability of digoxin.
    Shaw TR; Howard MR; Hamer J
    Lancet; 1972 Aug; 2(7772):303-7. PubMed ID: 4115034
    [No Abstract]   [Full Text] [Related]  

  • 27. Intersubject variation in absorption of digoxin in normal volunteers.
    Huffman DH; Manion CV; Azarnoff DL
    J Pharm Sci; 1975 Mar; 64(3):433-7. PubMed ID: 1151628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of digoxin bioavailability in single-dose studies.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    N Engl J Med; 1973 Sep; 289(13):651-4. PubMed ID: 4727968
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial: What the practicing physician should know about digoxin bioavailability and how will FDA action affect him?
    Circulation; 1974 Mar; 49(3):399-400. PubMed ID: 4813171
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological availability of digoxin.
    Shaw TR
    Br Heart J; 1973 May; 35(5):554-5. PubMed ID: 4577277
    [No Abstract]   [Full Text] [Related]  

  • 33. Bioavailability of digoxin tablets in healthy volunteers.
    Lee CH; Park YJ; Sands CD; Jones DW; Trang JM
    Arch Pharm Res; 1994 Apr; 17(2):80-6. PubMed ID: 10319136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes.
    Heizer WD; Pittman AW; Hammond JE; Fitch DD; Bustrack JA; Hull JH
    DICP; 1989 Oct; 23(10):764-9. PubMed ID: 2815851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of digoxin-tablet dissolution-rate with biological availability.
    Lindenbaum J; Butler VP; Murphy JE; Cresswell RM
    Lancet; 1973 Jun; 1(7814):1215-7. PubMed ID: 4122564
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide.
    Johnson BF; O'Grady J; Bye C
    Br J Clin Pharmacol; 1978 May; 5(5):465-7. PubMed ID: 656287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.
    Johnson BF; Bye C
    Br Heart J; 1975 Feb; 37(2):203-8. PubMed ID: 1091283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Greater bioavailability of digoxin solution in capsules. Studies in the postprandial state.
    Lindenbaum J
    Clin Pharmacol Ther; 1977 Mar; 21(3):278-82. PubMed ID: 576419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.